Invention Grant
- Patent Title: Immerse software-as-a-service patient empowerment platform for clinical trial participants
-
Application No.: US15129829Application Date: 2015-03-30
-
Publication No.: US10937527B2Publication Date: 2021-03-02
- Inventor: Thomas Klein , Matthieu-Patrick Schapranow , Ralf Schliehe-Diecks
- Applicant: Cytolon Digital Health AG
- Applicant Address: DE Berlin
- Assignee: Cytolon Digital Health AG
- Current Assignee: Cytolon Digital Health AG
- Current Assignee Address: DE Berlin
- Agency: Agris & von Natzmer LLP
- Agent Joyce von Natzmer
- Priority: EP14162208 20140328
- International Application: PCT/EP2015/056894 WO 20150330
- International Announcement: WO2015/144931 WO 20151001
- Main IPC: G16H10/20
- IPC: G16H10/20 ; G06Q50/22 ; G16H10/60 ; G06F21/62
Abstract:
The invention relates to system and a computer implemented method for use in the course of a clinical trial and/or precision medicine, wherein patient metrics are acquired and the system comprises selected core modules, methods and/or automated services and selected empowerment apps.
Public/Granted literature
- US20170154166A1 IMMERSE SOFTWARE-AS-A-SERVICE PATIENT EMPOWERMENT PLATFORM FOR CLINICAL TRIAL PARTICIPANTS Public/Granted day:2017-06-01
Information query
